ReviewReviews in endocrine & metabolic disorders2026
What is measured and what is estimated in body composition? A clarification framework for terminology and interpretation.
Review in Reviews in endocrine & metabolic disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Body composition assessment has traditionally focused on estimating body mass components and the estimation processes required to obtain them in vivo. Within this context, the five-level model and the methodological taxonomy proposed by Wang and colleagues provided a rigorous conceptual framework that has strongly shaped the field. However, contemporary research and practice reveal persistent ambiguity in the use of terms such as direct, indirect, and doubly indirect. This ambiguity has become increasingly evident as methods such as anthropometry and bioelectrical impedance analysis are widely used not only to estimate body mass components, but also to obtain whole-body variables that are directly measured and interpreted as clinically, physiologically, or performance-relevant descriptors. Confusion often arises when directly measured outputs (e.g., skinfolds, girths, phase angle) are not clearly distinguished from model-derived estimates of body composition (e.g., fat mass, fat-free mass). Accordingly, we propose a clarification framework for in vivo body composition assessment that distinguishes: (1) directly measured whole-body variables, (2) model-derived estimates of body composition, and (3) hybrid assessment pathways combining measured and inferred outputs. In this framework, classification depends on the specific variable of interest and the estimation process linking measurement to output, rather than on assigning a fixed label to the instrument itself. The term direct refers only to an output that is measured rather than model-derived, and does not imply direct assessment of body components, greater validity, or superior methodological accuracy. The proposed framework provides a practical conceptual tool for distinguishing measured from estimated body composition outputs, thereby improving methodological transparency, interpretation, and reporting consistency across research and clinical practice.
Indexed as
Identifiers
42397485What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.